Pulmonary embolism in two patients after severe hepatic trauma

Joanne K Claveria1, Michael T Meyer1, Martin K Wakeham1

  • 1Division of Pediatric Critical Care Medicine, Children's Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI, USA.

Insights

Severe hepatic trauma patients, especially children, face venous thromboembolism (VTE) risks. This case report highlights catheter-directed thrombolysis as a potential treatment for pediatric VTE following hepatic trauma.

Area of Science:

  • Pediatric Surgery
  • Vascular Surgery
  • Critical Care Medicine

Background:

  • Severe hepatic trauma necessitates damage control laparotomy and perihepatic packing, increasing venous thromboembolism (VTE) risk.
  • Existing VTE prevention and treatment guidelines are often extrapolated from adult data, posing challenges for pediatric patients.
  • Pediatric VTE management after major abdominal surgery requires specialized consideration.

Observation:

  • This case report details two pediatric patients who developed VTE, including pulmonary embolism, post-hepatic trauma surgery.
  • One patient experienced hemodynamically significant pulmonary emboli, treated successfully with catheter-directed thrombolysis.
  • The second patient presented with a vena caval thrombus and subsequent pulmonary embolism, managed with anticoagulation.

Findings:

  • Catheter-directed thrombolysis demonstrated efficacy in improving respiratory and hemodynamic status in a pediatric patient with severe pulmonary embolism.
  • Surveillance imaging identified VTE, enabling timely intervention and resource allocation.
  • Anticoagulation with heparin and enoxaparin was effective for managing vena caval and pulmonary thrombi in the second patient.

Implications:

  • Proactive surveillance imaging in pediatric hepatic trauma patients can facilitate the timely mobilization of critical resources like interventional radiology.
  • Catheter-directed thrombolysis emerges as a potentially viable and effective treatment for life-threatening VTE in critically ill pediatric surgical patients.
  • This experience underscores the need for tailored VTE management strategies in pediatric trauma care.

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
558
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
397
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
359
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219